<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-09T20:29:33+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>安进计划于年底向FDA 提交KRAS G12C抑制剂上市申请</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Yshb_URfYX0fuu4tuf2eEA</id>
    <link href="https://mp.weixin.qq.com/s/Yshb_URfYX0fuu4tuf2eEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采44个品种相关信息汇总（附清单下载）</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/BUinwWlNMWUNuyfDED-RPQ</id>
    <link href="https://mp.weixin.qq.com/s/BUinwWlNMWUNuyfDED-RPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药集团新冠灭活疫苗阿联酋获批上市，保护有效性达86%</title>
    <updated>2020-12-09T18:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/cLtME8NwBFe_KN-0oUAUzw</id>
    <link href="https://mp.weixin.qq.com/s/cLtME8NwBFe_KN-0oUAUzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞「哌柏西利」新剂型申请上市</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/MgnBmvYdSCCoezT9FkJ4Ow</id>
    <link href="https://mp.weixin.qq.com/s/MgnBmvYdSCCoezT9FkJ4Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月肺癌月报 | 重磅研究、高分综述、新开试验，一文洞悉最新进展！</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/XnbDPtbU9L-r49nvhfZMvg</id>
    <link href="https://mp.weixin.qq.com/s/XnbDPtbU9L-r49nvhfZMvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH2020 | 辉瑞公布CD3双抗治疗多发性骨髓瘤 I 期数据</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/Z6WBsIeiWXxcSy5b59iStw</id>
    <link href="https://mp.weixin.qq.com/s/Z6WBsIeiWXxcSy5b59iStw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生与Xencor达成CD28双抗开发合作</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/0OtUb2ZrvcnA-zeLiPuw_A</id>
    <link href="https://mp.weixin.qq.com/s/0OtUb2ZrvcnA-zeLiPuw_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞干眼病新药NOV03（全氟己基辛烷）获批临床</title>
    <updated>2020-12-08T19:31:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/zFDZ-LiiLMNgSBUxJsxdvg</id>
    <link href="https://mp.weixin.qq.com/s/zFDZ-LiiLMNgSBUxJsxdvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产PARP抑制剂！恒瑞医药氟唑帕利胶囊即将获批</title>
    <updated>2020-12-07T18:02:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/JEl66sJASCuQViio3csqoQ</id>
    <link href="https://mp.weixin.qq.com/s/JEl66sJASCuQViio3csqoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK贝利尤单抗新适应症获批</title>
    <updated>2020-12-07T18:02:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ZVeRciL_7ZDooKO698blGQ</id>
    <link href="https://mp.weixin.qq.com/s/ZVeRciL_7ZDooKO698blGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床急需新药「布罗舒单抗」即将获批上市</title>
    <updated>2020-12-07T18:02:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/PgauojV6TK5W8y8wDmf4SQ</id>
    <link href="https://mp.weixin.qq.com/s/PgauojV6TK5W8y8wDmf4SQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRISPR/ Cas9基因编辑疗法最新临床进展</title>
    <updated>2020-12-07T18:02:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/1uGPN9Mnbq5VGNdT-Leakw</id>
    <link href="https://mp.weixin.qq.com/s/1uGPN9Mnbq5VGNdT-Leakw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方核心行业数据监测周报（11月28-12月4日）</title>
    <updated>2020-12-07T18:02:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/_MIdRuqVZX-wyJG64ph7ww</id>
    <link href="https://mp.weixin.qq.com/s/_MIdRuqVZX-wyJG64ph7ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个CDK4/6抑制剂仿制药即将获批</title>
    <updated>2020-12-05T17:44:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/59YSRXer7x8AXmD_HQlL9Q</id>
    <link href="https://mp.weixin.qq.com/s/59YSRXer7x8AXmD_HQlL9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30亿祛痰品种！首个国产氨溴索吸入剂即将获批！</title>
    <updated>2020-12-04T17:07:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/4J_sLOI9Pg3AsqkitD7kvA</id>
    <link href="https://mp.weixin.qq.com/s/4J_sLOI9Pg3AsqkitD7kvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服遗传性血管性水肿新药获FDA批准</title>
    <updated>2020-12-04T17:07:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5iLhhGa-eT_m3lZUhQARuQ</id>
    <link href="https://mp.weixin.qq.com/s/5iLhhGa-eT_m3lZUhQARuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>AI助力新药研发！保诺科技与燧坤智能达成战略合作</title>
    <updated>2020-12-04T17:07:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Houm31SxRn7CohbpAjyhYQ</id>
    <link href="https://mp.weixin.qq.com/s/Houm31SxRn7CohbpAjyhYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4款仿制药通过一致性评价，扬子江2款</title>
    <updated>2020-12-04T17:07:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/oBb8-J0ReUMOBpO2zyAL7Q</id>
    <link href="https://mp.weixin.qq.com/s/oBb8-J0ReUMOBpO2zyAL7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！注射剂一致性评价排行榜</title>
    <updated>2020-12-03T18:17:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/O6unrRmRB55NBmCkNfFyJg</id>
    <link href="https://mp.weixin.qq.com/s/O6unrRmRB55NBmCkNfFyJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首款新冠病毒重组蛋白亚单位疫苗启动III期临床</title>
    <updated>2020-12-03T18:17:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/z7P8d-mbwmF7eEzFHtdUKg</id>
    <link href="https://mp.weixin.qq.com/s/z7P8d-mbwmF7eEzFHtdUKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>